Imatinib, a pan PDGFR tyrosine kinase inhibitor17, significantly inhibited TAM recruitment in A431, LLC and T241 tumours (Fig. 1e), suggesting that PDGFRs mediate PDGF-BB-induced TAM infiltration. The gene discussed is PDGFRB; the disease is neoplasm.